Immune pathway proteins

Immune pathway proteins" refers collectively to the many proteins that mediate cellular responses in the immune system, including but not limited to receptors (such as Toll-like receptors, cytokine receptors), enzymes (such as kinases and proteases), signaling molecules (such as chemokines and cytokines), transcription factors, and adhesion molecules. These proteins form intricate networks governing the recognition of pathogens, regulation of inflammation, activation and suppression of immune cell activity, antigen presentation, and maintenance of immune homeostasis. Due to their central role in immunology, numerous immune pathway proteins are individually validated as therapeutic targets for a wide range of diseases, including cancer (checkpoint inhibitors like PD-1/PD-L1, CTLA-4), autoimmunity (anti-cytokine antibodies), and infectious and inflammatory diseases [1][2][3][4][6][7]. However, "Immune pathway proteins" as a phrase does not designate a single drug target and should not be used in place of a specific molecule for precise therapeutic or mechanistic studies. If you seek structured information for a particular protein or pathway within the immune system, such as "Programmed cell death protein 1 (PD-1)" or "Toll-like receptor 4," a precise query is necessary to retrieve target-specific data.

Other names

immune regulatorsimmune signaling proteinsimmune checkpointsimmune effectorsimmune mediators